Long-term graft patency after CABG: effects of distal anastomosis angle

Similar documents
Radial Artery Grafting: Why Do It? (Evidence Basis)

Mandatory knowledge about natural history of coronary grafts. P.Sergeant P. Maureira K.U.Leuven, Belgium

Importance of the third arterial graft in multiple arterial grafting strategies

FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium

Chapter 45. Utility of Computed Tomographic Coronary Angiography Post Coronary Revascularization BACKGROUND CORONARY ARTERY BYPASS GRAFTING

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

Incremental Value of Multiple Arterial conduits in CABG

Sotirios N. Prapas, M.D., Ph.D, F.E.C.T.S.

Declaration of conflict of interest NONE

SURGICAL MYOCARDIAL REVASCULARIZATION: ARTERIAL VS VENOUS GRAFTS, SINGLE VS MULTIPLE GRAFTS?

Coronary Artery Imaging. Suvipaporn Siripornpitak, MD Inter-hospital Conference : Rajavithi Hospital

OPCABG for Full Myocardial Revascularisation How we do it

Left main coronary artery (LMCA): The proximal segment

Declaration of interest conflicts. None

How I deploy arterial grafts

MICS CABG. Putting the future of MICS in your hands today

T the ST segment during attacks caused by coronary

The SYNTAX-LE MANS Study

Form 4: Coronary Evaluation

Myocardial revascularization without cardiopulmonary

high SYNTAX Score? I Sheiban Division of Cardiology Interventional Card. University of Turin Turin / Italy

SUPPLEMENTAL MATERIAL

Distal end side-to-side anastomoses of sequential vein graft to small target coronary arteries improve intraoperative graft flow

On-Pump vs. Off-Pump CABG: The Controversy Continues. Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery

Diagnostic, Technical and Medical

The use of both the left and right internal thoracic arteries (ITAs) for revascularization

Form 4: Coronary Evaluation

Improved long-term survival has been demonstrated by

CABG for ischemic cardiomyopathy, post myocardial infarction and cardiogenic shock

HOW TO PREPARE A GOOD ACCEPTED

Unprotected LM intervention

Michael Mack, M.D. Baylor Healthcare System Heart Hospital Baylor Plano Dallas, TX

CORONARY ARTERY BYPASS GRAFTING (CABG) (Part 1) Mark Shikhman, MD, Ph.D., CSA Andrea Scott, CST

The Second Best Arterial Graft:

Robotic & Hybrid Coronary Revascularization

Surgical Options for revascularisation P E T E R S U B R A M A N I A M

Implications of the New ESC/EACTS Guidelines for Myocardial Revascularization in 2011

J. Schwitter, MD, FESC Section of Cardiology

Is bypass surgery needed for elderly patients with LMT disease? From the surgical point of view

Minimally invasive direct coronary artery bypass for left anterior descending artery revascularization analysis of 300 cases

Most Patients with Elective Left Main Disease. Farrel Hellig

Rational use of imaging for viability evaluation

Surgery for Acquired Cardiovascular Disease

Form 4: Coronary Evaluation

David A. Orsinelli, MD, FACC, FASE Professor, Internal Medicine The Ohio State University Division of Cardiovascular Medicine Columbus, Ohio

CORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW

GIANT CORONARY ARTERY ANEURYSM FOLLOWING SIROLIMUS-ELUTING STENT IMPLANTATION. D S Gambhir MD, DM, FAMS. FACC

Disclosures The PREVENT IV Trial was supported by Corgentech and Bristol-Myers Squibb

Pallav J. Shah a, Manoj Durairaj a, Ian Gordon b, John Fuller c, Alex Rosalion a, Siven Seevanayagam a, James Tatoulis c, Brian F.

Optimal Conduit Strategy in 2017

Coronary Artery Bypass Grafting Using the Gastroepiploic Artery in 1,000 Patients

Intraoperative Fluorescence Imaging System for On-Site Assessment of Off-Pump Coronary Artery Bypass Graft

PCI for Left Main Coronary Artery Stenosis. Jean Fajadet Clinique Pasteur, Toulouse, France

Safe Approach for Redo Coronary Artery Bypass Grafting Preventing Injury to the Patent Graft to the Left Anterior Descending Artery

TSDA ACGME Milestones

Form 4: Coronary Evaluation

Revascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing

DECISION - CTO. optimal Medical Treatment in patients with. Seung-Jung Park, MD, PhD, FACC for the DECISION-CTO Study investigators

#1 G.S. Kassab Mathematical modeling of coronary arterial tree

FFR-guided Jailed Side Branch Intervention

FFR vs. icecg in Coronary Bifurcations (FIESTA) - preliminary results. Dobrin Vassilev MD, PhD National Heart Hospital Sofia, Bulgaria

It has been recognized worldwide that the use of the left internal thoracic

Case Presentation #1

Easy. Not so Easy. Risk Assessment in the CLI Patient: Who is Likely to Benefit from Revascularization and Who is Not? 4/28/2012

The most important advantage of CABG over PTCA is its

DESCRIPTION: Percentage of patients aged 18 years and older undergoing isolated CABG surgery who received an IMA graft

Early Angiographic Results of Multivessel Off-Pump Coronary Artery Bypass Grafting

Popliteal Aneurysm: When is surgical therapy indicated? PROF. GRZEGORZ OSZKINIS

Emergency surgery in acute coronary syndrome

Percutaneous Intervention of Unprotected Left Main Disease

VCU Pauley Heart Center: A 2009 US News Top 50 Heart and Heart Surgery Hospital

Cardiac Viability Testing A Clinical Perspective Annual Cardiac Imaging Symposium. Lisa M Mielniczuk MD FRCPC University of Ottawa Heart Institute

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

Successful revascularization of LCX-CTO via a underlying

Multiple PCI of SVG-LAD and SVG-OM graft vessel in a Bangladeshi patient starting 7 years after

EACTS Adult Cardiac Database

ΑΝΤΙΓΝΩΜΙΕΣ ΣΤΗΝ ΕΠΕΜΒΑΤΙΚΗ ΚΑΡΔΙΟΛΟΓΙΑ:Νόσος στελέχους Αγγειοπλαστική

Technical Aspects and Initial Experience in Off-Pump Coronary Artery Bypass Grafting

CONTEMPORARY USE OF ARTERIAL GRAFTS DURING CORONARY ARTERY BYPASS SURGERY: PARADIGM SHIFT? OR A LITTLE (MORE) TALK THAT NEEDS A LOT MORE ACTION

Mario Gaudino*, Francesco Alessandrini, Claudio Pragliola, Carlo Cellini, Franco Glieca, Nicola Luciani, Fabiana Girola, Gianfederico Possati

What do the guidelines say?

Stable Ischemic Heart Disease. Ivan Anderson, MD RIHVH Cardiology

Bilateral IMA Grafting CONTRA

Off-pump coronary artery bypass (OPCAB) grafting has

Declaration of conflict of interest. Nothing to disclose

Revascularization for Patients with HFrEF: CABG and PCI and the Concept of Myocardial Viability

Heart may be rotated but not compressed

TEE guided TAVR using BASILICA technique in patient with stenotic Freestyle aortic bioprosthesis

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome

Potential conflicts of interest

ROBOTIC CARDIAC SURGERY

Received 20 January 2008; received in revised form 30 June 2008; accepted 11 July 2008; Available online 23 August 2008

Surgery Grand Rounds

Patencies of 2,127 Arterial to Coronary Conduits Over 15 Years

Cardiac, Vascular and Transplant Surgery Quality Assessment. Intraoperative Ultrasound Imaging and TTFM

Coronary artery surgery results In The Survey Committee of Japanese Association for Coronary Artery Surgery (JACAS)

CASE from South Korea

DECISION-CTO. Optimal Medical Therapy With or Without Stenting For Coronary Chronic Total Occlusion. Seung-Jung Park, MD., PhD.

Solving the Dilemma of Ostial Stenting: A Case Series Illustrating the Flash Ostial System

Journal of Cardiothoracic Surgery 2012, 7:12

Transcription:

Long-term graft patency after CABG: effects of distal anastomosis angle Grigore Tinica 1,2, Raluca Chistol 1, Mihail Enache 1,2, Cristina Furnica 2 1 Cardiovascular Institute, Iasi, Romania 2 Gr. T. Popa University of Medicine and Pharmacy, Iasi, Romania

The author has no conflict of interest to disclose with respect to this presentation

Background What do we know? GRAFT PATENCY Key determinant of long term outcome post CABG GRAFT CHOICE Additional arterial grafts (including RA) COMPLETE REVASCULARIZATION 2-4 grafts /5-6 distal anastomoses SURGICAL SKILLS Composite grafting, sequential and Y/T anastomoses, conduit selection and preparation, graft/target vessel match Factors affecting patency omorphological features (vessel type, graft length and diameter); ophysiological factors (e.g. competitive flow, degenerative vascular changes); osurgical parameters technical expertise, graft harvesting and preparation, grafting design and anastomosis technique ( single, sequential, composite, Y/T, angle of anastomosis). Nowadays it is considered that everything is almost known in terms of CABG surgery. The optimal choice of conduit and configuration for CABG is still controversial. The weak point remains the correct intraoperatory evaluation of the factors that might influence long term graft patency. There are few studies analyzing the most important morphological features to consider such as length, luminal diameter, wall thickness, and histological characteristics of the conduit. This is why we try through this study to outline the surgical, morphological and physiological factors that might stabilize the results. Which and how are the surgical, morphological and physiological factors associated with long-term grafts patency?

Study design and follow up CABG 2000-2006 397 patients operated 340 grafts Evaluated graft variables : type and status (cfr OR protocol); target artery (cfr OR protocol); target vessel caliber; graft length and caliber; anastomosis type (cfr OR protocol); anastomosis angles. 2.68 grafts/patient 399 distal anastomoses 3.14 anastomoses/patient 128 unresponsive patients 269 patients evaluated 127 CCTA 10-16 yrs post-cabg (139.78±36.64 mo) 220 (55.14%) anastomoses using arterial grafts 179 (44.86%) SVG 122 LITA, 53 RA, 45 RITA Postoperative medical treatment: beta blockers, statins, and enteric-coated aspirin in all cases; RA graft - calcium channel blocker (Amlodipine) for the first 3 months to prevent spasm; treatment adjusted according to the blood pressure, left ventricular ejection fraction (LVEF) and comorbidities. Inclusion: more 10yrs First CABG Age > 18 years No contraindication for CCTA Good quality CCTA Informed Consent Complete medical file (demographic data; anthropometrical data - height, weigh; perioperative data, follow-up data) Exclusion:less 10yrs Prior CABG No Informed Consent CCTA contraindications Poor quality CCTA Incomplete medical file.

Significant difference between the anastomosis angle of patent versus occluded grafts (p = 0.015), a smaller angle being registered in case of patent anastomosis. 100 90 80 70 60 50 40 30 20 10 0 Patent grafts were longer and not tensed Patient s height (cm) Graft s length (mm) Patent Occluded p Patent Occluded p SVG 171 170 n.s. 133 122 n.s. LIMA 170 172 n.s. 202 182 0.1 RIMA (Y) 171 165 0.06 96 84 0.08 RAG 174 168 0.06 133 114 0.1 82.54 56.25 69.56 83.33 75.56 92.86 80.65 64.71 57.14 CX Diag RCA LAD SVG RAG RIMA LIMA 90.17 Patency rates according to coronary territory Target vessel Results Stenosis severity 3.02 occlusion OR for arterial grafts anastomosed to target vessels with <90% stenosis (p<0.001). Proximal anastomosis type Overall graft patency at 10 to 16 (11,6) years was of 90.17% for the LITA, 79.25% for the RA, 76% for the RITA, and 74.3% for the SVG. Proximal (Y/T ) anastomosis angle 47.21 o mean angle for Y/T anastomoses with both grafts patent - 47.21 o vs. 56 o for anastomoses with occlusion of the free arterial graft (RA or RITA). Vessel calibre ( 1.5 mm) being associated with 2.63 occlusion OR for SVGs (p=0.0041) and 2.31 occlusion OR for arterial grafts (p=0.0001) Significant association of graft patency with proximal anastomosis type 0.110 occlusion OR (p = 0.002) for RA anastomosed to the ascending aorta - protective effect against graft failure. 47.21

Results Anastomosis angle in distal sequential grafting: 48.60 o for patent vs. 53.97 o for occluded side-to-side anastomoses, 65.12 o for patent vs. 90.80 o for occluded end-to-side anastomoses, irrespective to graft type. Anastomosis angle in single end-to-side: arterial grafts sensitive to the anastomosis angle with a mean value of 39.46 o for patent grafts and 44.94 o for occluded ones (p = 0.034); venous grafts - non-significant difference; and registered higher patency rates in sequential designs AUC - cut-off angle 60 o for an occlusion OR of 5.149 for arterial grafts in case of distal anastomosis angle 60 o B S.E. Wald df Sig. Exp(B) 95% C.I.for EXP(B) (p<0.001). Prognostic value of distal anastomosis angle Lower Upper Step 1 a Angle 1.639.444 13.630 1.000 5.149 2.157 12.292 Constant -2.367.302 61.476 1.000.094 a. Variable(s) entered on step 1: paliere unghi. Measurement of distal sideto-side (A), distal end-toside (B), and Y (C) anastomosis angle

Discussions RAG-LCX territory RIMA-RCA territory <90% target vessel stenosis with arterial grafts Target vessel calibre <1.5 mm Independent predictors of graft dysfunction How to decide? Our decisions: Young patients + diffuse CAD TAR; Elderly patients (>70-80 yrs) more SVGs; Target vessel degree of stenosis (70% - 90%); Co-morbidities (COPD, DM, PVD, RD...); Surgeon s experience; Operative team (simultaneous harvesting); Adequate Number of Anastomoses (Ø>1.5mm); Type of anastomoses (Y/T/Π/ Ψ ); Designed the graft arhitecture for each patient. Proximal Y anastomosis for RAG Y anastomosis angle >56 o Distal anastomosis angle >60 o Patent grafts longer than occluded ones. Graft tension and kinking avoided. a larger graft-to-host diameter ratios (5:3) - better hemodynamic than smaller ones (1:1) uniform and large WSS, small WSSG; smaller grafts typically - risk of early graft failure due to thrombosis. Hemodynamic factors: Wall shear stress (WSS), WSS spatial+temporal gradients, Oscillatory shear index (OSI). AIM - optimal patency-enhancing CABG anastomotic configuration ALTERATION IH Graft dysfunction In our opinion, an optimal CABG design should include a graft adapted to target vessel territory and degree of stenosis, with distal anastomosis angle under 60 o, Y anastomosis angle under 56 o, and a good caliber match. The most significant factors in graft patency is flawless surgical technique in order to tailor a patient-specific designs.

Conclusions Occlusion rate was higher in <1.5 mm target vessels calibre for both arterial and SVG grafts; RA grafts registered higher patency rates when anastomosed to the ascending aorta compared with composite grafting with LITA, A small anastomosis angle, both for proximal Y and distal anastomoses was associated with higher long-term patency of the free arterial graft; Long term graft patency correlates directly with patient specific anastomosis design; In situ RITA anastomosed to the right coronary territory is associated with a lower patency rate compared with free RITA used to revascularise the anterolateral or CX territory as part of composite grafting. Long grafts in taller patients register higher patency rates compared to short grafts in shorter patients; a small length reserve (smooth curvatures) is required to ensure free-of-tension graft; The current study - prove in situ the effect of distal anastomosis angle on graft patency and represents a potential start point for multi-institutional research.

Tinica et al. Long-term graft patency after CABGAnatol J Cardiol 2018; 20: 275-82

Muchas Gracias! Thank you! Muito Obrigado! Mulțumesc!